
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR-Cas knockout of miR21 reduces glioma growth
Lisa Nieland, Thomas S. van Solinge, Pike-See Cheah, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 121-136
Open Access | Times Cited: 26
Lisa Nieland, Thomas S. van Solinge, Pike-See Cheah, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 121-136
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 59
Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 59
Using ncRNAs as Tools in Cancer Diagnosis and Treatment—The Way towards Personalized Medicine to Improve Patients’ Health
Roberto Piergentili, Giuseppe Basile, Cristina Nocella, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9353-9353
Open Access | Times Cited: 59
Roberto Piergentili, Giuseppe Basile, Cristina Nocella, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9353-9353
Open Access | Times Cited: 59
Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review
Gayathree Thenuwara, James F. Curtin, Furong Tian
Sensors (2023) Vol. 23, Iss. 24, pp. 9842-9842
Open Access | Times Cited: 39
Gayathree Thenuwara, James F. Curtin, Furong Tian
Sensors (2023) Vol. 23, Iss. 24, pp. 9842-9842
Open Access | Times Cited: 39
CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review
Emir Begagić, Hakija Bečulić, Nermin Đuzić, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 238-238
Open Access | Times Cited: 16
Emir Begagić, Hakija Bečulić, Nermin Đuzić, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 238-238
Open Access | Times Cited: 16
Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages
Stoyan Tankov, Marija Petrovic, Marc Lecoultre, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Stoyan Tankov, Marija Petrovic, Marc Lecoultre, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Synthetic miR-21 decoy circularized by tRNA splicing mechanism inhibited tumorigenesis in glioblastoma in vitro and in vivo models
Hadi Bayat, Mohammad H. Pourgholami, Saeid Rahmani, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 432-444
Open Access | Times Cited: 14
Hadi Bayat, Mohammad H. Pourgholami, Saeid Rahmani, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 432-444
Open Access | Times Cited: 14
The Multifaceted Role of miR-21 in Pancreatic Cancers
Clare Chen, Lusine Demirkhanyan, Christopher S. Gondi
Cells (2024) Vol. 13, Iss. 11, pp. 948-948
Open Access | Times Cited: 5
Clare Chen, Lusine Demirkhanyan, Christopher S. Gondi
Cells (2024) Vol. 13, Iss. 11, pp. 948-948
Open Access | Times Cited: 5
Molecular mechanisms of microRNAs in glioblastoma pathogenesis
Amir Barzegar Behrooz, Hamid Latifi‐Navid, Akram Nezhadi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 6, pp. 119482-119482
Closed Access | Times Cited: 13
Amir Barzegar Behrooz, Hamid Latifi‐Navid, Akram Nezhadi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 6, pp. 119482-119482
Closed Access | Times Cited: 13
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma
Arthur Bassot, Helena Dragic, Sarah Al Haddad, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 12
Arthur Bassot, Helena Dragic, Sarah Al Haddad, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 12
Nucleic acid-based therapy for brain cancer: Challenges and strategies
Zixia Zhang, João Conniot, Joana Amorim, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 80-92
Open Access | Times Cited: 19
Zixia Zhang, João Conniot, Joana Amorim, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 80-92
Open Access | Times Cited: 19
Exploring miR-21 Knock-Out Using CRISPR/Cas as a Treatment for Lung Cancer
Patricia Lara, Araceli Aguilar-González, Francisco Martı́n, et al.
Genes (2025) Vol. 16, Iss. 2, pp. 133-133
Open Access
Patricia Lara, Araceli Aguilar-González, Francisco Martı́n, et al.
Genes (2025) Vol. 16, Iss. 2, pp. 133-133
Open Access
Role of miRNA in adult ocular tumorigenesis
Arianna Romani, E. Melloni, Giada Lodi, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Arianna Romani, E. Melloni, Giada Lodi, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Glioblastoma preclinical models: Strengths and weaknesses
Vasavi Pasupuleti, Lalitkumar K. Vora, Renuka Prasad, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189059-189059
Open Access | Times Cited: 8
Vasavi Pasupuleti, Lalitkumar K. Vora, Renuka Prasad, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189059-189059
Open Access | Times Cited: 8
Roles of extracellular vesicles in glioblastoma: foes, friends and informers
Taral R. Lunavat, Lisa Nieland, Anne B. Vrijmoet, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Taral R. Lunavat, Lisa Nieland, Anne B. Vrijmoet, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives
Edgar G. Ordóñez-Rubiano, Nicolás Rincón-Arias, Sebastián Espinosa, et al.
Current Research in Pharmacology and Drug Discovery (2024) Vol. 7, pp. 100193-100193
Open Access | Times Cited: 2
Edgar G. Ordóñez-Rubiano, Nicolás Rincón-Arias, Sebastián Espinosa, et al.
Current Research in Pharmacology and Drug Discovery (2024) Vol. 7, pp. 100193-100193
Open Access | Times Cited: 2
New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets
Bashdar Mahmud Hussen, Khozga Hazhar Abdullah, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 4, pp. 645-660
Open Access | Times Cited: 6
Bashdar Mahmud Hussen, Khozga Hazhar Abdullah, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 4, pp. 645-660
Open Access | Times Cited: 6
miR-26 Deficiency Causes Alterations in Lens Transcriptome and Results in Adult-Onset Cataract
Anil Upreti, Thanh Hoang, Minghua Li, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 4, pp. 42-42
Open Access | Times Cited: 1
Anil Upreti, Thanh Hoang, Minghua Li, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 4, pp. 42-42
Open Access | Times Cited: 1
miRNA-targeting oligonucleotide constructs with various mechanisms of action as effective inhibitors of carcinogenesis
С. К. Мирошниченко, Olga Patutina, Marina A. Zenkova
Biological Products Prevention Diagnosis Treatment (2024) Vol. 24, Iss. 2, pp. 140-156
Open Access | Times Cited: 1
С. К. Мирошниченко, Olga Patutina, Marina A. Zenkova
Biological Products Prevention Diagnosis Treatment (2024) Vol. 24, Iss. 2, pp. 140-156
Open Access | Times Cited: 1
Autophagy-associated biomarkers ULK2, UVRAG, and miRNAs miR-21, miR-126, and miR-374: Prognostic significance in glioma patients
Wajiha Amin, Syed Ather Enam, Sufiyan Sufiyan, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0311308-e0311308
Open Access | Times Cited: 1
Wajiha Amin, Syed Ather Enam, Sufiyan Sufiyan, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0311308-e0311308
Open Access | Times Cited: 1
Systems Medicine for Precise Targeting of Glioblastoma
Jie Zeng, Xiao Xue Zeng
Molecular Biotechnology (2023) Vol. 65, Iss. 10, pp. 1565-1584
Open Access | Times Cited: 2
Jie Zeng, Xiao Xue Zeng
Molecular Biotechnology (2023) Vol. 65, Iss. 10, pp. 1565-1584
Open Access | Times Cited: 2
Autophagy-Associated Markers LC3-II, ULK2 and microRNAs miR-21, miR-126 and miR-374 as a Potential Prognostic Indicator for Glioma Patients
Wajiha Amin, Syed Ather Enam, Sufiyan Sufiyan, et al.
(2023)
Open Access | Times Cited: 1
Wajiha Amin, Syed Ather Enam, Sufiyan Sufiyan, et al.
(2023)
Open Access | Times Cited: 1
Autophagy-Associated Markers LC3-II, ULK2 and microRNAs miR-21, miR-126 and miR-374 as a Potential Prognostic Indicator for Glioma Patients
Wajiha Amin, Syed Ather Enam, Sufiyan Sufiyan, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Wajiha Amin, Syed Ather Enam, Sufiyan Sufiyan, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Application of novel CRISPR tools in brain therapy
Jiawen Shang, Fei Song, Zhenzhong Zhang, et al.
Life Sciences (2024) Vol. 352, pp. 122855-122855
Closed Access
Jiawen Shang, Fei Song, Zhenzhong Zhang, et al.
Life Sciences (2024) Vol. 352, pp. 122855-122855
Closed Access
Cell-Based Glioma Models for Anticancer Drug Screening: From Conventional Adherent Cell Cultures to Tumor-Specific Three-Dimensional Constructs
Daria Lanskikh, Olga Kuziakova, Ivan Baklanov, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2085-2085
Open Access
Daria Lanskikh, Olga Kuziakova, Ivan Baklanov, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2085-2085
Open Access
CRISPR/Cas gene editing and its application in the treatment of Gliomas in the brain
Raymond Wai‐Yin Sun
Highlights in Science Engineering and Technology (2024) Vol. 123, pp. 684-691
Closed Access
Raymond Wai‐Yin Sun
Highlights in Science Engineering and Technology (2024) Vol. 123, pp. 684-691
Closed Access